Skip to main content
. 2020 Oct 27;3:620. doi: 10.1038/s42003-020-01339-9

Fig. 2. Arl8b on lysosomes enhances lysosomal exocytosis and invasiveness.

Fig. 2

a Arl8b in the lysosomal fraction of MDA-MB-231 cells. Markers of the nucleus (Histone H3), lysosomes (Rab9) and the cytoskeleton (β-actin) were stained with antibodies. The amount of Arl8b in the lysosomal fraction was normalized against LAMP1. b Total Arl8b in whole-cell lysates of MDA-MB-231 cells after IR treatment was detected by immunoblotting. c, d Arl8b-mVenus overexpression was induced by doxycycline (c) and assessed by confocal fluorescence microscopy (d). Dox, doxycycline. Green, Arl8b-mVenus; red, LysoTracker. Bar, 10 μm. e Lysosomal distribution in Arl8b-mVenus-overexpressing MDA-MB-231 cells. Pseudocolor micrographs with lysosomes shown in red (LAMP1), microtubules shown in blue (α-tubulin), and nuclei shown in white (DAPI). Bar, 10 μm. f LAMP1 fluorescence intensities in each region. The intensity of region 0 was excluded. Points and connecting lines, means; bars, SEMs. g LAMP1 fluorescence intensity in the cell periphery (regions 3 and 4). Bars, SEMs. h Matrigel chemoinvasion assay of Arl8b-mVenus-overexpressing MDA-MB-231 cells. Representative images of the results were obtained from the Matrigel invasion assays. i Immunofluorescence images showing essential proteases in Arl8b-positive lysosomes. Blue, proteases; green, Arl8b-mVenus; red, LysoTracker. Bar, 10 μm. All column graphs show the means with SEMs of three independent experiments. The results of each group in column graphs were normalized against that of the untreated group. *P < 0.05; ***P < 0.001; ns, not significant.